DSK Legal provided legal advice to the Asian Institute of Medical Sciences on an exit strategy for its private equity investors, facilitating significant financial transitions.
DSK Legal Guides Asian Institute on Investor Exit
DSK Legal recently advised the Asian Institute of Medical Sciences on strategically providing an exit to its private equity investors, OrbiMed Asia II Mauritius Limited and British International Investment. This transition was accomplished through a private credit facility coordinated with 360 ONE, coupled with refinancing efforts by Hero FinCorp relating to an existing loan facility from HDFC Bank.
The legal guidance offered by DSK Legal encompassed multiple facets including the acquisition process and negotiation of terms, essential to facilitating this financial maneuver. The advice underscores the firm's capability in navigating complex financial transactions within the healthcare sector.
This advisory role illustrates the intersection of legal expertise and business strategy, particularly for healthcare institutions engaging with private equity.
“We provided comprehensive legal guidance throughout the exit strategy process for the institute.”
For legal practitioners in the corporate sector, this case exemplifies best practices in advising healthcare entities on investment transactions, highlighting key considerations in structuring exits for investors.
Citations
- Asian Institute of Medical Sciences v. Investors (2026) DSK Legal Advisory
